ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Merck KGaA at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Merck KGaA takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1034. Its sessions focus on treatment developments in colorectal cancer and care for rare desmoid tumours. They also examine whether time without bladder cancer returning can serve as a substitute for overall survival in muscle-invasive disease.
| Organization | ESMO 2026 Attendance |
|---|---|
German science and technology company whose healthcare business markets oncology medicines including avelumab, cetuximab and tepotinib. | Booth Exhibiting at Booth 1034 Poster Fri Oct 23 13:00–15:00 Satellite Sat Oct 24 13:00–14:30 Merck Healthcare KGaA - Striving for more: The cutting edge of therapeutic developments in mCRC Gastrointestinal cancers Satellite Mon Oct 26 13:00–14:30 Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Merck KGaA
Tell us what you sell and we’ll find the people at Merck KGaA most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction